Gilead Sciences
GILD
$67.65
Share price
0.16%
Change (1 day)
-13.69%
Change (1 year)
Categories
Market capitalization of Gilead Sciences (GILD)
Market cap: $84.28 Billion
As of May 2024 Gilead Sciences has a market cap of $84.28 Billion. This makes Gilead Sciences the world's 202th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Gilead Sciences from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $84.28 B | -16.5% |
| 2023 | $100.94 B | -6.25% |
| 2022 | $107.67 B | 18.26% |
| 2021 | $91.05 B | 24.68% |
| 2020 | $73.03 B | -11.22% |
| 2019 | $82.26 B | 2.59% |
| 2018 | $80.18 B | -14.31% |
| 2017 | $93.58 B | -0.81% |
| 2016 | $94.34 B | -34.43% |
| 2015 | $143.89 B | 1.84% |
| 2014 | $141.29 B | 22.62% |
| 2013 | $115.23 B | 106.55% |
| 2012 | $55.79 B | 81.47% |
| 2011 | $30.74 B | 5.78% |
| 2010 | $29.06 B | -25.35% |
| 2009 | $38.93 B | -16.39% |
| 2008 | $46.56 B | 8.95% |
| 2007 | $42.73 B | 42.74% |
| 2006 | $29.94 B | 23.89% |
| 2005 | $24.16 B | 53.89% |
| 2004 | $15.70 B | 26.36% |
| 2003 | $12.42 B | 84.99% |
| 2002 | $6.71 B | 5.91% |
| 2001 | $6.34 B |
End of Day market cap according to different sources
On May 13th, 2024 the market cap of Gilead Sciences was reported to be:
$84.14 Billion
$84.14 Billion
$84.18 Billion
$84.14 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $364.32 B | 332.27% | 🇺🇸 USA |
 Pfizer PFE | $160.81 B | 90.81% | 🇺🇸 USA |
 AbbVie ABBV | $285.34 B | 238.56% | 🇺🇸 USA |
 Eli Lilly LLY | $726.09 B | 761.50% | 🇺🇸 USA |
 Amgen AMGN | $167.05 B | 98.21% | 🇺🇸 USA |
 Biogen BIIB | $33.03 B | -60.81% | 🇺🇸 USA |
 Illumina ILMN | $18.41 B | -78.15% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $110.59 B | 31.23% | 🇺🇸 USA |
 Merck MRK | $325.87 B | 286.65% | 🇺🇸 USA |